JP2001523959A5 - - Google Patents

Download PDF

Info

Publication number: JP2001523959A5
Authority: JP; Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

JP1998546254A

Other languages

English (en)

Other versions

JP2001523959A (ja

Filing date

1998-04-21

Publication date

2005-12-02

1998-04-21 Application filed filed Critical

1998-04-21 Priority claimed from PCT/US1998/007968 external-priority patent/WO1998048009A2/en

2001-11-27 Publication of JP2001523959A publication Critical patent/JP2001523959A/ja

2005-12-02 Publication of JP2001523959A5 publication Critical patent/JP2001523959A5/ja

Status Ceased legal-status Critical Current

Description

JP54625498A 1997-04-21 1998-04-21 疾患のリボザイム処置のための物質および方法 Ceased JP2001523959A (ja)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US4449297P	1997-04-21	1997-04-21
US60/044,492		1997-04-21
US4614797P	1997-05-09	1997-05-09
US60/046,147		1997-05-09
PCT/US1998/007968 WO1998048009A2 (en)	1997-04-21	1998-04-21	Materials and methods for ribozyme treatment of retinal diseases

Publications (2)

Publication Number	Publication Date
JP2001523959A JP2001523959A (ja)	2001-11-27
JP2001523959A5 true JP2001523959A5 (ja)	2005-12-02

Family

ID=26721633

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP54625498A Ceased JP2001523959A (ja)	1997-04-21	1998-04-21	疾患のリボザイム処置のための物質および方法

Country Status (8)

Country	Link
US (1)	US6225291B1 (ja)
EP (1)	EP0977841A2 (ja)
JP (1)	JP2001523959A (ja)
AU (1)	AU735788B2 (ja)
BR (1)	BR9808606A (ja)
CA (1)	CA2287508A1 (ja)
NZ (1)	NZ500427A (ja)
WO (1)	WO1998048009A2 (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0977841A2 (en)	1997-04-21	2000-02-09	University Of Florida	Materials and methods for ribozyme treatment of retinal diseases
DE19956568A1 (de) *	1999-01-30	2000-08-17	Roland Kreutzer	Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens
JP2002542805A (ja)	1999-04-30	2002-12-17	ユニバーシティオブフロリダ	アデノ随伴ウイルス送達リボザイム組成物および使用方法
WO2000066720A2 (en) *	1999-04-30	2000-11-09	City Of Hope	The use of adeno-associated virus (aav) deliver cytoprotective genes
US7829693B2 (en) *	1999-11-24	2010-11-09	Alnylam Pharmaceuticals, Inc.	Compositions and methods for inhibiting expression of a target gene
US8546143B2 (en)	2001-01-09	2013-10-01	Alnylam Pharmaceuticals, Inc.	Compositions and methods for inhibiting expression of a target gene
US20030003582A1 (en) *	2001-05-08	2003-01-02	Tranzyme, Inc.	Trans-viral vector mediated gene transfer to the retina
EP1495120B1 (en)	2002-04-18	2012-10-10	Acuity Pharmaceuticals, Inc	Means and methods for the specific modulation of target genes in the eye
US7148342B2 (en)	2002-07-24	2006-12-12	The Trustees Of The University Of Pennyslvania	Compositions and methods for sirna inhibition of angiogenesis
WO2004042027A2 (en)	2002-11-04	2004-05-21	University Of Massachusetts	Allele-specific rna interference
US8680063B2 (en)	2003-09-12	2014-03-25	University Of Massachusetts	RNA interference for the treatment of gain-of-function disorders
EP1937066A4 (en)	2005-08-18	2008-12-24	Alnylam Pharmaceuticals Inc	METHOD AND COMPOSITIONS FOR THE TREATMENT OF NERVOUS DISEASES
CA2683469C (en)	2007-04-12	2019-11-26	The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth	Genetic suppression and replacement
SG171952A1 (en)	2008-12-04	2011-07-28	Opko Ophthalmics Llc	Compositions and methods for selective inhibition of pro-angiogenic vegf isoforms
WO2010127209A2 (en) *	2009-04-30	2010-11-04	The Research Foundation Of State University Of New York	Compositions and methods for therapy of macular degeneration
RS58434B1 (sr)	2010-04-23	2019-04-30	Univ Florida	Sastavi raav-guanilatne ciklaze i postupci tretiranja leberove urođene amauroze-1 (lca1)
DK3137497T3 (da)	2014-05-02	2021-07-12	Genzyme Corp	Aav-vektorer til retinal- og cns-genterapi
CA2961523A1 (en)	2014-09-16	2016-03-24	Genzyme Corporation	Adeno-associated viral vectors for treating myocilin (myoc) glaucoma
EP4012035A1 (en)	2014-09-16	2022-06-15	Genzyme Corporation	Adeno-associated viral vectors for treating myocilin (myoc) glaucoma
BR112017017178A2 (pt)	2015-02-26	2018-04-03	Ionis Pharmaceuticals Inc	moduladores específicos de alelo de rodopsina de p23h
US11653636B2 (en) *	2019-11-15	2023-05-23	University Of Ulsan Foundation For Industry Cooperation	Method of making a rat model of retinal degeneration and rat model made thereby
CN115989234A (zh)	2020-01-29	2023-04-18	建新公司	用于眼部基因疗法的经修饰的腺相关病毒衣壳蛋白及其使用方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5116742A (en)	1986-12-03	1992-05-26	University Patents, Inc.	RNA ribozyme restriction endoribonucleases and methods
US5037746A (en)	1986-12-03	1991-08-06	University Patents, Inc.	RNA ribozyme polymerases, and methods
US4987071A (en)	1986-12-03	1991-01-22	University Patents, Inc.	RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
US5646020A (en)	1992-05-14	1997-07-08	Ribozyme Pharmaceuticals, Inc.	Hammerhead ribozymes for preferred targets
US5498539A (en) *	1992-07-02	1996-03-12	Daiichi Pharmaceutical Co., Ltd.	Bovine endothelial nitric oxide synthase nucleic acids
US5639655A (en)	1993-01-19	1997-06-17	Ribozyme Pharmaceuticals, Inc.	PML-RARA targeted ribozymes
US6410322B1 (en)	1993-07-27	2002-06-25	Hybridon Inc	Antisense oligonucleotide inhibition of vascular endothelial growth factor expression
US5646031A (en)	1995-05-16	1997-07-08	Northern Illinois University	SArMV and sCYMVI hairpin ribozymes
GB9519299D0 (en)	1995-09-21	1995-11-22	Farrar Gwyneth J	Genetic strategy
GB9604449D0 (en)	1996-03-01	1996-05-01	Farrar Gwyneth J	Genetic strategy ii
WO1998048027A2 (en) *	1997-04-21	1998-10-29	University Of Florida	Materials and methods for treatment of retinal diseases
EP0977841A2 (en)	1997-04-21	2000-02-09	University Of Florida	Materials and methods for ribozyme treatment of retinal diseases

1998
- 1998-04-21 EP EP98918493A patent/EP0977841A2/en not_active Withdrawn
- 1998-04-21 WO PCT/US1998/007968 patent/WO1998048009A2/en not_active Application Discontinuation
- 1998-04-21 NZ NZ500427A patent/NZ500427A/xx unknown
- 1998-04-21 JP JP54625498A patent/JP2001523959A/ja not_active Ceased
- 1998-04-21 BR BR9808606-5A patent/BR9808606A/pt not_active IP Right Cessation
- 1998-04-21 AU AU71406/98A patent/AU735788B2/en not_active Ceased
- 1998-04-21 US US09/063,667 patent/US6225291B1/en not_active Expired - Lifetime
- 1998-04-21 CA CA002287508A patent/CA2287508A1/en not_active Abandoned

Publication	Publication Date	Title
JP2000509912A5 (ja)	2005-09-08
JP2000509942A5 (ja)	2007-09-06
JP2000510751A5 (ja)	2005-10-06
JP2000509637A5 (ja)	2005-10-06
JP2000509635A5 (ja)	2005-10-06
JP2001524836A5 (ja)	2005-12-02
JP2001523240A5 (ja)	2005-12-02
JP2000509587A5 (ja)	2005-09-08
JP2002508747A5 (ja)	2005-12-02
JP2001508794A5 (ja)	2005-05-12
JP2000508866A5 (ja)	2005-09-08
JP2000510793A5 (ja)	2005-07-14
JP2000508841A5 (ja)	2005-10-06
JP2001514522A5 (ja)	2005-10-06
JP2000508680A5 (ja)	2005-11-24
JP2000509804A5 (ja)	2005-10-06
JP2000509853A5 (ja)	2006-03-02
JP2000510969A5 (ja)	2005-09-08
JP2000509755A5 (ja)	2005-10-06
JP2001524146A5 (ja)	2005-11-24
JP2000508836A5 (ja)	2005-09-08
JP2001523959A5 (ja)	2005-12-02
JP2000509818A5 (ja)	2004-10-28
JP2000510247A5 (ja)	2005-09-08
JP2000509520A5 (ja)	2005-09-08